Kwon Yunhyung, Choe Young June, Yun Jae-Won, Kim Hee Kyoung, Kim Sungnam, Chun Chaemin, Jung Yeon Haw, Kim HeeJung, Oh Hyun-Kyung, Lee Yeonkyoeng, Lee Jae Young, Lee Seon Kui, Park Young-Joon
Director for Epidemiological Investigation Analysis, Korea Disease Control and Prevention Agency, Cheongju 28159, Korea.
Department of Pediatrics, Korea University Anam Hospital, Seoul 02841, Korea.
Vaccines (Basel). 2021 Apr 10;9(4):367. doi: 10.3390/vaccines9040367.
Increased awareness of adverse events following immunization (AEFI) can disrupt vaccination programs. In South Korea, a report of alleged influenza vaccine-related deaths attracted significant media attention in 2020. We retrieved the vaccination coverage and AEFI data to determine their association with media coverage. Between 2015 and 2019, the vaccination coverage rate ranged between 80.5% and 83.3%; however, the vaccination coverage rate declined significantly from 2020 to 2021 to 73.6% ( < 0.0001). During the 43rd week of 2020, following a large amount of media coverage on vaccine safety issues, the number of cases with AEFI reached 60. Between 2015 and 2020, the mortality rate ratios for influenza vaccines and non-vaccines ranged between 0.1296 (95% confidence interval (CI), 0.1262-0.1331, < 0.0001) and 0.1608 (95% CI, 0.1572-0.1644, < 0.0001). Vaccine safety surveillance should be continued in conjunction with investigation and transparent risk communication to maintain public trust in vaccines and vaccinations.
对免疫接种后不良事件(AEFI)的认识增加可能会扰乱疫苗接种计划。在韩国,2020年一份关于所谓流感疫苗相关死亡的报告引起了媒体的广泛关注。我们检索了疫苗接种覆盖率和AEFI数据,以确定它们与媒体报道之间的关联。2015年至2019年期间,疫苗接种覆盖率在80.5%至83.3%之间;然而,2020年至2021年期间,疫苗接种覆盖率显著下降至73.6%(<0.0001)。在2020年第43周,在媒体大量报道疫苗安全问题之后,AEFI病例数达到60例。2015年至2020年期间,流感疫苗与未接种疫苗的死亡率比值在0.1296(95%置信区间(CI),0.1262 - 0.1331,<0.0001)和0.1608(95%CI,0.1572 - 0.1644,<0.0001)之间。应继续进行疫苗安全监测,并结合调查和透明的风险沟通,以维持公众对疫苗和疫苗接种的信任。